Jones Financial Companies’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Jones Financial Companies's JAZZ Position: Q2 2026 in Review
Jones Financial Companies increased its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q2 2026, buying an estimated $779K and bringing the position to 21,710 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1194.
Jones Financial Companies first reported a position in JAZZ in Q2 2022 and has held it in 10 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Jones Financial Companies held 21,710 shares of Jazz Pharmaceuticals worth $4.99M as of Q2 2026.
- Jones Financial Companies bought 3,558 Jazz Pharmaceuticals shares in Q2 2026, an estimated $779K.
- Jazz Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1194 holding.
- Jones Financial Companies first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.